Canada markets closed

Nordicus Partners Corporation (NORD)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
0.60000.0000 (0.00%)
At close: 02:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.6000
Open0.8000
Bid0.5000 x 0
Ask0.8000 x 0
Day's Range0.8000 - 0.8000
52 Week Range0.4500 - 0.9200
Volume1,376
Avg. Volume130
Market Cap29.479M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In Denmark

    Beverly Hills, California., June 21, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced it entered into a Consultancy Agreement with BIO-CONVERT in Denmark. BIO-CONVERT ApS (“BIO-CONVERT”) is a clinical-stage biopharmaceutical company focused on revolutionizing the trea

  • GlobeNewswire

    Orocidin – New Insights Into The Treatment Of Periodontitis

    Beverly Hills, California., June 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, and its 95% owned subsidiary, Orocidin A/S (“Orocidin”), announced today new insights into the treatment of periodontitis. Orocidin’s preclinical product is called QR-01 and has a novel mode of acti

  • GlobeNewswire

    Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors

    Beverly Hills, California, June 04, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, announced today the appointment of Peter Severin as Chairman of the Board of Directors. Peter Severin replaces Christian Hill-Madsen as Chairman, who resigned to focus on developing the next generati